---
schema_version: "secwatch.filing_event.v1"
accession: "0000014272-24-000020"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T09:51:44.622476+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bristol Myers Q4 rev up 1% to $11.5B; Non-GAAP EPS $1.70; FY rev $45.0B; 2024 EPS guide $7.10-$7.40

## Summary
- Fourth quarter revenues $11.5B (+1% YoY); GAAP EPS $0.87, Non-GAAP EPS $1.70.
- Full-year revenues $45.0B (-2% YoY); GAAP EPS $3.86, Non-GAAP EPS $7.51.
- In-line & new product portfolio revenues: +9% in Q4, +7% in FY to $37.9B.
- 2024 guidance: revenue growth low single-digits; Non-GAAP EPS $7.10-$7.40 (excl. pending acquisitions).
- Pipeline: FDA approval of Augtyro; Breyanzi sBLAs accepted; completed Mirati purchase, pending Karuna & RayzeBio.

## SEC filing metadata
- accession: 0000014272-24-000020
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000001427224000020/0000014272-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000001427224000020/bmy-20240202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000014272-24-000020
- JSON: https://secwatch.observer/filing/0000014272-24-000020.json
- Plain text: https://secwatch.observer/filing/0000014272-24-000020.txt

## Key facts
- Earnings Releases
  BRISTOL MYERS SQUIBB CO reported the fourth quarter of 2023 results: revenue $11,477, EPS GAAP EPS of $0.87 and Non-GAAP EPS of $1.70.
  - Period: the fourth quarter of 2023
  - Revenue: $11,477
  - EPS: GAAP EPS of $0.87 and Non-GAAP EPS of $1.70
  - Result: reported results
  source text: the decade and beyond." 1 Fourth Quarter Full Year $ in millions, except per share amounts 2023 2022 Change Change Excl. F/X** 2023 2022 Change Change Excl. F/X** Total Revenues $11,477 $11,406 1 % 1 % $45,006 $46,159 (2) % (2) % EPS — GAAP* 0.87 0.95 (8) % N/A 3.86 2.95 31 % N/A EPS — Non-GAAP* 1.70 1.82 (7) % N/A 7.51 7.70 (2) % N/A Acquired IPRD charge and
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000001427224000020/0000014272-24-000020-index.htm
- Earnings Releases
  BRISTOL MYERS SQUIBB CO reported full year of 2023 results: revenue $45,006, EPS GAAP EPS of $3.86 and Non-GAAP EPS of $7.51. Guidance initiated.
  - Period: full year of 2023
  - Revenue: $45,006
  - EPS: GAAP EPS of $3.86 and Non-GAAP EPS of $7.51
  - Guidance: initiated
  - Result: reported results
  source text: 1 Fourth Quarter Full Year $ in millions, except per share amounts 2023 2022 Change Change Excl. F/X** 2023 2022 Change Change Excl. F/X** Total Revenues $11,477 $11,406 1 % 1 % $45,006 $46,159 (2) % (2) % EPS — GAAP* 0.87 0.95 (8) % N/A 3.86 2.95 31 % N/A EPS — Non-GAAP* 1.70 1.82 (7) % N/A 7.51 7.70 (2) % N/A Acquired IPRD charge and Licensing Income Net Impact
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000001427224000020/0000014272-24-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.